Form D · Biotechnology
Kuleana Technology, Inc.
Seattle, WA · CIK 0001923795
Offering snapshot reported Apr 25, 2022 · SEC filing
- Reported sold
- $250K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2022 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443121
Source: Form D, filed Apr 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Himmelfarb | Director, Executive |
| Buddy Ratner | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
98 Union St. Apt.1000
Seattle, WA, 98101
Seattle, WA, 98101